Vysioneer Advances AI-Powered Treatment Efficacy Assessment in Prospective Oncology Clinical Trials
PR Newswire (AI)en
PR Newswire (AI)
AI Global WireVysioneer Inc. announced the prospective deployment of its VTrial AI platform in a pharma-sponsored oncology clinical trial to ...
This is a short summary published by AI Global Wire. The full article is owned and hosted by PR Newswire (AI) — open it there to read it in full.
Read the full story at PR Newswire (AI)Related AI news
- Sources: OpenAI has retreated from advocating for strict US chip export controls to China ahead of the lame-duck session, aligning closer with President Trump (Politico)Techmeme · October 20, 2026
- Nvidia backs four German startups as European spending spree continuesSifted · October 20, 2026
- 9일째 러닝머신 걷는 로봇…560km·120만 걸음 돌파ETNews (KR) · October 20, 2026
- Microsoft: Behandla AI-agenter som insiderhotComputer Sweden · October 20, 2026
- Arda, which develops AI software and agents to accelerate assembly line programming and manufacturing automation, raised $230M at a $1.5B valuation (Kate Rooney/CNBC)Techmeme · October 20, 2026
- AI-verktyg kan förutsäga cancerpatienters chanser med en selfieComputer Sweden · October 20, 2026